US EditionPublished • loading... • Updated
Clonal Hematopoiesis Linked to Increased Heart Disease Risk in Cancer Patients Receiving Treatment
About 20% of cancer patients have CHIP mutations linked to higher 10-year heart failure and ischemic disease risk, supporting pre-treatment screening and cardiac monitoring.
Summary by News Medical
3 Articles
3 Articles
Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatment
About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP).
·United States
Read Full Article
Hidden blood mutations linked to higher heart disease risk after cancer treatment
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). A study by Vanderbilt Health researchers reveals that it puts them at increased risk for heart disease following cancer treatment.
The key is in clonal hematopoyesis, which is characterized by age-related variants in blood stem cells and is usually asymptomatic.
·Spain
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
